Zecotek Photonics - die Aktie 2008 (Seite 342)
eröffnet am 29.11.07 14:46:26 von
neuester Beitrag 25.04.24 11:43:24 von
neuester Beitrag 25.04.24 11:43:24 von
Beiträge: 29.056
ID: 1.135.811
ID: 1.135.811
Aufrufe heute: 0
Gesamt: 2.793.809
Gesamt: 2.793.809
Aktive User: 0
ISIN: CA98921P1045 · WKN: A0M8QZ · Symbol: ZMSPF
0,0000
USD
0,00 %
0,0000 USD
Letzter Kurs 23.03.24 Nasdaq OTC
Werte aus der Branche Sonstige Technologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,6800 | +17,48 | |
| 2,0000 | +14,29 | |
| 0,7500 | +11,11 | |
| 0,5150 | +9,57 | |
| 1,0000 | +7,64 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 250,00 | -7,41 | |
| 2,0700 | -8,41 | |
| 1,1900 | -9,16 | |
| 0,5160 | -9,47 | |
| 18,950 | -10,61 |
Beitrag zu dieser Diskussion schreiben
Feedback
Hey kommt, das ist wirklich eine gute Nachricht und das wird der Markt auch annerkennen.
Antwort auf Beitrag Nr.: 55.014.342 von bullish1969 am 25.05.17 10:07:15endschuldigt meine Schreibweise. Es fließen bei mir langsam emotionale Komponenten mit ein bei dieser Aktie.
Antwort auf Beitrag Nr.: 55.014.261 von Mick1968 am 25.05.17 09:59:58ja leider ist da so. MM wirkt leider ein bisschen überheblich und unseriös, der alte Schweizer. Die Wissensschaftler und Ingenieure halte ich dagegen für fähig, sind aber eben keine Steve Jobs.
Antwort auf Beitrag Nr.: 55.014.213 von bullish1969 am 25.05.17 09:56:49Genau so sehe ich das auch.
Ich kann mich an Telefonaten erinnern wo Hr. Minder gelacht hat wo die frage aufgekommen ist wann wir bei 2 Euro stehen.
So wird das nie was.
Ich kann mich an Telefonaten erinnern wo Hr. Minder gelacht hat wo die frage aufgekommen ist wann wir bei 2 Euro stehen.
So wird das nie was.
Antwort auf Beitrag Nr.: 55.014.036 von Cargoli am 25.05.17 09:33:19Hört sich eigentlich ganz gut an, nur befürchte ich, durch die Art und Weise der Berichtserstattung und deren Umsetzung über die letzten Jahre, verpuffen solche Nachrichten bei uns Anlegern. Zuviel Vertrauen ist über die Jahre verloren gegangen. Bevor nicht Kapital im großen Stil generiert wird, wird die Aktie leider dieses Niveau beibehalten. Ich beschreibe nur die Marktstimmung die ich fühle. Dennoch bleibe ich überzeugt das irgendwann der erhoffte Durchbruch kommt. Nur eben wann ...? Ich schätze mal, wenn alles so stimmt wie geschrieben, müsste ende diesen Jahres die Aktie nur ein Ziel kennen, und zwar Richtung Norden - denn tiefer kann es wohl kaum gehen.
Trading Spotlight
Antwort auf Beitrag Nr.: 55.014.036 von Cargoli am 25.05.17 09:33:19Und was willst du damit sagen ??
Solche News hatten wir schon mindestens 10 mal und was hat es gebracht seit 2008 ?
Kursverfall und Erhöhung der Aktien.
Solche News hatten wir schon mindestens 10 mal und was hat es gebracht seit 2008 ?
Kursverfall und Erhöhung der Aktien.
Antwort auf Beitrag Nr.: 55.001.274 von Mick1968 am 23.05.17 15:35:20Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices
Singapore, May 25, 2017 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that two additional Chinese, tier 1 positron emission tomography (PET) OEM integrators have successfully tested and qualified it patented LFS scintillation crystals for use in their current product lines of PET medical scanners.
“Our exclusive supply agreement with EBO Optoelectronics is starting to take shape with now three tier 1 PET OEMs having tested and qualified our patented LFS scintillation crystals for use in their respective medical scanners,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “These three tier 1 OEMs have decided that the LFS crystal has all the economical and physical characteristics needed for their long-term production of PET medical scanners.”
EBO Optoelectronics is the largest crystal array producer and supplier in China and uses Zecotek’s LFS scintillation crystals exclusively for their PET arrays. It has an extensive and impressive international customer list including the top PET OEMs in the world, and exclusively serves China, the second largest medical device market in the world. As China experiences rapid economic growth and an aging population, the Chinese government has made significant investments in the medical system directly and through regulations and incentives. Domestic OEMs have taken advantage of these resources and are now producing leading medical scanners. Medical administrators in North America and Europe now look to China for leading edge medical technology like PET scanning devices.
Zecotek has created a strategic partnership with EBO Optoelectronics with the goal of becoming the leading supplier of scintillation crystals and other the key components in China and around the world.
About Shanghai EBO Optoelectronics Co. Ltd.
Founded in 2007 and headquartered in Shanghai, EBO has more than 120 employees and 4,000 square meters of manufacturing space. Shanghai EBO fabricates and supplies crystal arrays to an extensive customer base which includes: Neusoft Medical Systems, Samsung Medical, Topgrade Healthcare, FMI Medical Systems, IHEP of CAS, Huazhong University of Science and Technology, and many domestic and foreign universities and research institutions. EBO has the highest standard processing production line and offers shaped crystal customization and crystal array assembly to end users.
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visitwww.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
Michael Minder
T: (604) 783-8291
ir@zecotek.com
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Singapore, May 25, 2017 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that two additional Chinese, tier 1 positron emission tomography (PET) OEM integrators have successfully tested and qualified it patented LFS scintillation crystals for use in their current product lines of PET medical scanners.
“Our exclusive supply agreement with EBO Optoelectronics is starting to take shape with now three tier 1 PET OEMs having tested and qualified our patented LFS scintillation crystals for use in their respective medical scanners,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “These three tier 1 OEMs have decided that the LFS crystal has all the economical and physical characteristics needed for their long-term production of PET medical scanners.”
EBO Optoelectronics is the largest crystal array producer and supplier in China and uses Zecotek’s LFS scintillation crystals exclusively for their PET arrays. It has an extensive and impressive international customer list including the top PET OEMs in the world, and exclusively serves China, the second largest medical device market in the world. As China experiences rapid economic growth and an aging population, the Chinese government has made significant investments in the medical system directly and through regulations and incentives. Domestic OEMs have taken advantage of these resources and are now producing leading medical scanners. Medical administrators in North America and Europe now look to China for leading edge medical technology like PET scanning devices.
Zecotek has created a strategic partnership with EBO Optoelectronics with the goal of becoming the leading supplier of scintillation crystals and other the key components in China and around the world.
About Shanghai EBO Optoelectronics Co. Ltd.
Founded in 2007 and headquartered in Shanghai, EBO has more than 120 employees and 4,000 square meters of manufacturing space. Shanghai EBO fabricates and supplies crystal arrays to an extensive customer base which includes: Neusoft Medical Systems, Samsung Medical, Topgrade Healthcare, FMI Medical Systems, IHEP of CAS, Huazhong University of Science and Technology, and many domestic and foreign universities and research institutions. EBO has the highest standard processing production line and offers shaped crystal customization and crystal array assembly to end users.
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visitwww.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
Michael Minder
T: (604) 783-8291
ir@zecotek.com
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
Naja ist nur eine frage der Menge,
1 Kristall oder mehr ??
1 Dollar oder mehrere ??
Das ist wieder nur wischi waschi Sorry
Zahlen sind das wichtigste sonst glaubt Zecotek wieder keiner.
1 Kristall oder mehr ??
1 Dollar oder mehrere ??
Das ist wieder nur wischi waschi Sorry
Zahlen sind das wichtigste sonst glaubt Zecotek wieder keiner.
Antwort auf Beitrag Nr.: 54.998.718 von NoamX am 23.05.17 09:53:56@NoamX
Bezüglich der Angelegenheit Spital in Singapore bist du offensichtlich nicht auf dem aktuellen Stand.
Solltest wohl mal die entsprechende Unternehmensnachricht durchlesen dann beantwortet sich deine Frage.
Coolbleiben
Bezüglich der Angelegenheit Spital in Singapore bist du offensichtlich nicht auf dem aktuellen Stand.
Solltest wohl mal die entsprechende Unternehmensnachricht durchlesen dann beantwortet sich deine Frage.
Coolbleiben
Antwort auf Beitrag Nr.: 54.998.718 von NoamX am 23.05.17 09:53:56...na ja wenn 4 Bestellungen keine substanziellen Infos sind weiss ich auch nicht... Näheres wie immer , leider, dann scheibchenweise im Nachgang...
wegen dem Krankenhaus in China kannst Du ja mal bei Michael Minder anrufen... würde echt mal Zeit für infos
die Dinge entwickeln sich
wegen dem Krankenhaus in China kannst Du ja mal bei Michael Minder anrufen... würde echt mal Zeit für infos
die Dinge entwickeln sich
Durchsuchen
